Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001144204-16-128173
Filing Date
2016-10-14
Accepted
2016-10-14 16:31:43
Documents
63

Document Format Files

Seq Description Document Type Size
1 POS AM v450480_posam.htm POS AM 1061484
2 EXHIBIT 23.2 v450480_ex23-2.htm EX-23.2 2321
3 GRAPHIC tlogo.jpg GRAPHIC 6142
  Complete submission text file 0001144204-16-128173.txt   5019811

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT antb-20160630.xml EX-101.INS 820903
5 XBRL TAXONOMY EXTENSION SCHEMA antb-20160630.xsd EX-101.SCH 51380
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE antb-20160630_cal.xml EX-101.CAL 44226
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE antb-20160630_def.xml EX-101.DEF 339258
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE antb-20160630_lab.xml EX-101.LAB 378526
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antb-20160630_pre.xml EX-101.PRE 379727
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: POS AM | Act: 33 | File No.: 333-196093 | Film No.: 161937356
SIC: 2834 Pharmaceutical Preparations